CSG's First Quarterly Report Arrives Amid Short-Seller Fallout and EU Funding Deadline

Czech defense group CSG enters pivotal week with first earnings report since IPO, SAFE program deadline, and recovery from short-seller attack that halved stock value.

The Czech defense group CSG enters a pivotal week with three major catalysts converging: its inaugural quarterly report as a publicly traded company, a looming deadline for cheap EU financing under the SAFE program, and lingering doubts from a short-seller attack that has wiped out half the stock's value since January. At Friday's close of €16.42, shares have shed 51% from their 52-week high, and the 30-day annualized volatility has climbed to nearly 73% — a symptom of the deep unease gripping investors.

The selloff was triggered in early May by a report from Hunterbrook Media, which disclosed a short position and alleged that CSG merely refurbishes old ammunition rather than manufacturing new rounds. The company flatly rejected the analysis as inaccurate, pointing to 630,000 cartridges produced last year and a target of 20% growth in 2026. A new production line in Slovakia is expected to add 70,000 units alone, with a medium-term goal of reaching an internal capacity of 1.1 million cartridges annually.

Despite the market's skepticism, CSG's underlying operational performance remains robust. Revenue reached €6.74 billion in the prior fiscal year, with an adjusted operating margin of 24.1%. Management has reaffirmed its 2026 forecast of €7.4?billion to €7.6?billion in sales and an EBIT margin between 24% and 25%. The order backlog stood at €14?billion at the end of September, a 69% year-on-year increase, and swells to €42?billion when including long-term framework agreements. Moody's recently upgraded CSG’s secured bonds to Baa3.

The May 20 earnings release will be the first detailed look at post-IPO finances, including the one-off costs of January’s listing. Investors will be watching for hard data on production volumes, cash flow, and whether the operating margin has absorbed the listing expenses without damage. A strong number could help the management rebut Hunterbrook's allegations with concrete evidence.

Meanwhile, a critical deadline is approaching at the end of May for the SAFE financing program. Slovakia’s framework agreement — with a maximum volume of €58?billion — qualifies for loans at a 1% interest rate only if at least two EU member states participate. So far only Slovakia is committed. Romania’s defense ministry has denied ministerial-level talks, while Croatia is still evaluating the option. Without a second participant, CSG may lose access to exceptionally cheap funding for its Slovak ammunition expansion.

On the product side, CSG showcased the new CFL-120 Karpat main battle tank at the IDEB 2026 arms fair in Bratislava, developed jointly with Turkey’s FNSS. Weighing up to 34 tonnes and reaching 70?km/h with a range of 450?km, the tank combines an FNSS chassis, CSG manufacturing in Slovakia, and the Leonardo HITFACT® MkII turret with a 120?mm gun. Serial production is planned in Slovakia. Separately, CSG has announced the acquisition of a 49% stake in Austrian ammunition specialist Hirtenberger Defence Systems and a broad cooperation with Poland’s PGZ group on drone engines and land platforms.

Analysts remain steadfastly bullish. All nine covering the stock rate it a buy, with JPMorgan’s target at €40 and the consensus at €35.40. That implies more than double the current share price. The gap between analyst optimism and market reality will narrow — or widen — on Wednesday, when CSG delivers its first quarterly test as a listed company.